BioXcel Therapeutics Inc (BTAI)
2.55
+0.01
(+0.39%)
USD |
NASDAQ |
May 02, 15:34
BioXcel Therapeutics Gross Profit (TTM): 0.119M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.119M |
| September 30, 2023 | 0.686M |
| June 30, 2023 | 0.983M |
| March 31, 2023 | 0.552M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.355M |
| September 30, 2022 | 0.126M |
| June 30, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Jun 2022
0.983M
Maximum
Jun 2023
0.403M
Average
0.355M
Median
Dec 2022
Gross Profit (TTM) Benchmarks
| Synlogic Inc | -- |
| Cormedix Inc | 0.00 |
| Bristol-Myers Squibb Co | 34.48B |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | 53.16M |